Work

Pharmacokinetics and Safety of TPN171 (a PDE5 Inhibitor) in Patients With Mild or Moderate Hepatic Impairment Versus Participants With Normal Hepatic Function: A Phase 1 Study

Year: 2025

Type: article

Study design: Clinical Trial

Source: Clinical Pharmacology in Drug Development

DOI: 10.1002/cpdd.1535

Authors: Jing Zhou, Hong Zhang, Yanhua Ding, Zhen Wang, Yu Wang, Jiaxiang Juan, Zhicheng Jiang, Hong Chen

Institutions: First Hospital of Jilin University, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, State Key Laboratory of Drug Research, Vigonvita Life Sciences Co., Ltd. (China)

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409805144

FWCI: 0.857

Cites: 22

Cited by: 1

Related to: 10